This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

Troutman Pepper Locke

| less than a minute read

From Zero to 100% – New Section 232 Tariffs on Patented Drugs and the High-Stakes Onshoring and MFN Choices Ahead

New Section 232 tariffs impose up to 100% duties on patented drugs while offering relief tied to onshoring and MFN pricing commitments.